Advancing new antibody treatments for immunological and inflammatory disorders.
Advancing new antibody treatments for immunological and inflammatory disorders. Headquartered in Watertown, MA. Raised $65M in Series C funding in June 2026 led by Ascenta Capital.
Biotechnology📍 Watertown, MA
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Triveni Bio going public?
No. Triveni Bio is private and has not filed to go public. There is no S-1 on file.
What is Triveni Bio's valuation in 2026?
No confirmed valuation is on record for Triveni Bio. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Triveni Bio filed an S-1?
No public S-1 is on file for Triveni Bio.
Who are Triveni Bio's investors?
Triveni Bio's investors include Ascenta Capital, Janus Henderson Investors, Deep Track Capital.
How much has Triveni Bio raised?
Triveni Bio has raised $65M in total across 1 disclosed round, most recently a Series C of $65M in Jun 2026.
Is Triveni Bio publicly traded — can you buy Triveni Bio stock?
No. Triveni Bio is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Triveni Bio on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Vishal Patel
HQ
Watertown, MA
Total Raised
$65M
Last Round
Series C — $65M (Jun 2026) · Lead: Ascenta Capital
go-to-market push — Only 0% of open roles build product — hiring is concentrated in sales/marketing/ops (1 of 2 open roles are other).
Open roles trending down; no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Director, AI and Data ScienceDirector, Business Development
Counted from Triveni Bio's live job board as of 2026-09-14; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Investors
Ascenta Capital · Janus Henderson Investors · Deep Track Capital
BiotechnologyPharmaceuticalsRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.